These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 30691533)
1. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy. Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533 [TBL] [Abstract][Full Text] [Related]
2. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy. Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731 [TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease. Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944 [TBL] [Abstract][Full Text] [Related]
4. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379 [TBL] [Abstract][Full Text] [Related]
5. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696 [TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340 [TBL] [Abstract][Full Text] [Related]
7. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy. Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503 [TBL] [Abstract][Full Text] [Related]
8. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Manousopoulou A; Gatherer M; Smith C; Nicoll JAR; Woelk CH; Johnson M; Kalaria R; Attems J; Garbis SD; Carare RO Neuropathol Appl Neurobiol; 2017 Oct; 43(6):492-504. PubMed ID: 27543695 [TBL] [Abstract][Full Text] [Related]
9. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519 [TBL] [Abstract][Full Text] [Related]
11. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ. Miners JS; Clarke P; Love S Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. Cho HS; Hyman BT; Greenberg SM; Rebeck GW J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869 [TBL] [Abstract][Full Text] [Related]
13. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Chalmers K; Wilcock GK; Love S Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death. Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483 [TBL] [Abstract][Full Text] [Related]
15. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. Holtzman DM J Mol Neurosci; 2004; 23(3):247-54. PubMed ID: 15181253 [TBL] [Abstract][Full Text] [Related]
16. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease. Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972 [TBL] [Abstract][Full Text] [Related]